Global Targeted Protein Degradation Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 3/1/2023
- NO OF PAGES
- 250
- CATEGORY
- Healthcare & Life Sciences
Targeted Protein Degradation market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain which gives brief strategy of market growth during the forecast period. It also gives in-depth insights on SWOT and PESTLE analysis based on industry segmentations and regional developments.
Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Targeted Protein Degradation market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Targeted Protein Degradation manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Targeted Protein Degradation market covering all its essential aspects.
Global Targeted Protein Degradation Market: Segmentations
Global Targeted Protein Degradation Market: By Types
Oral
Intravenous
Others
Global Targeted Protein Degradation Market: By Applications
Hospital
Research Institute
Global Targeted Protein Degradation Market: Major Players
5AM Venture Management LLC
AbbVie Inc
Almac Group
Amgen Inc.
Bayer AG
Biogen Inc.
C4 Therapeutics
Cosmo Bio USA
Covance Inc
Eli Lilly and Company
Gilead Sciences, Inc
GlaxoSmithKline plc
Merck KGaA
Mission Therapeutics
Novartis AG
Pfizer Inc
Promega
Global Targeted Protein Degradation Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Targeted Protein Degradation market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Targeted Protein Degradation would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Targeted Protein Degradation Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Base Year: 2023Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Targeted Protein Degradation market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Targeted Protein Degradation manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Targeted Protein Degradation market covering all its essential aspects.
Global Targeted Protein Degradation Market: Segmentations
Global Targeted Protein Degradation Market: By Types
Oral
Intravenous
Others
Global Targeted Protein Degradation Market: By Applications
Hospital
Research Institute
Global Targeted Protein Degradation Market: Major Players
5AM Venture Management LLC
AbbVie Inc
Almac Group
Amgen Inc.
Bayer AG
Biogen Inc.
C4 Therapeutics
Cosmo Bio USA
Covance Inc
Eli Lilly and Company
Gilead Sciences, Inc
GlaxoSmithKline plc
Merck KGaA
Mission Therapeutics
Novartis AG
Pfizer Inc
Promega
Global Targeted Protein Degradation Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Targeted Protein Degradation market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Targeted Protein Degradation would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Targeted Protein Degradation Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1 Market Overview
1.1 Product Overview and Scope of Targeted Protein Degradation
1.2 Classification of Targeted Protein Degradation by Type
1.2.1 Overview: Global Targeted Protein Degradation Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Targeted Protein Degradation Revenue Market Share by Type in 2022
1.2.3 Oral
1.2.4 Intravenous
1.2.5 Others
1.3 Global Targeted Protein Degradation Market by Application
1.3.1 Overview: Global Targeted Protein Degradation Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Hospital
1.3.3 Research Institute
1.4 Global Targeted Protein Degradation Market Size & Forecast
1.5 Global Targeted Protein Degradation Market Size and Forecast by Region
1.5.1 Global Targeted Protein Degradation Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Targeted Protein Degradation Market Size by Region, (2016-2021)
1.5.3 North America Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.5.4 Europe Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.5.6 South America Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Targeted Protein Degradation Market Drivers
1.6.2 Targeted Protein Degradation Market Restraints
1.6.3 Targeted Protein Degradation Trends Analysis
2 Company Profiles
2.1 5AM Venture Management LLC
2.1.1 5AM Venture Management LLC Details
2.1.2 5AM Venture Management LLC Major Business
2.1.3 5AM Venture Management LLC Targeted Protein Degradation Product and Solutions
2.1.4 5AM Venture Management LLC Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 5AM Venture Management LLC Recent Developments and Future Plans
2.2 AbbVie Inc
2.2.1 AbbVie Inc Details
2.2.2 AbbVie Inc Major Business
2.2.3 AbbVie Inc Targeted Protein Degradation Product and Solutions
2.2.4 AbbVie Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 AbbVie Inc Recent Developments and Future Plans
2.3 Almac Group
2.3.1 Almac Group Details
2.3.2 Almac Group Major Business
2.3.3 Almac Group Targeted Protein Degradation Product and Solutions
2.3.4 Almac Group Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Almac Group Recent Developments and Future Plans
2.4 Amgen Inc.
2.4.1 Amgen Inc. Details
2.4.2 Amgen Inc. Major Business
2.4.3 Amgen Inc. Targeted Protein Degradation Product and Solutions
2.4.4 Amgen Inc. Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Amgen Inc. Recent Developments and Future Plans
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Targeted Protein Degradation Product and Solutions
2.5.4 Bayer AG Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Bayer AG Recent Developments and Future Plans
2.6 Biogen Inc.
2.6.1 Biogen Inc. Details
2.6.2 Biogen Inc. Major Business
2.6.3 Biogen Inc. Targeted Protein Degradation Product and Solutions
2.6.4 Biogen Inc. Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Biogen Inc. Recent Developments and Future Plans
2.7 C4 Therapeutics
2.7.1 C4 Therapeutics Details
2.7.2 C4 Therapeutics Major Business
2.7.3 C4 Therapeutics Targeted Protein Degradation Product and Solutions
2.7.4 C4 Therapeutics Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 C4 Therapeutics Recent Developments and Future Plans
2.8 Cosmo Bio USA
2.8.1 Cosmo Bio USA Details
2.8.2 Cosmo Bio USA Major Business
2.8.3 Cosmo Bio USA Targeted Protein Degradation Product and Solutions
2.8.4 Cosmo Bio USA Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Cosmo Bio USA Recent Developments and Future Plans
2.9 Covance Inc
2.9.1 Covance Inc Details
2.9.2 Covance Inc Major Business
2.9.3 Covance Inc Targeted Protein Degradation Product and Solutions
2.9.4 Covance Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Covance Inc Recent Developments and Future Plans
2.10 Eli Lilly and Company
2.10.1 Eli Lilly and Company Details
2.10.2 Eli Lilly and Company Major Business
2.10.3 Eli Lilly and Company Targeted Protein Degradation Product and Solutions
2.10.4 Eli Lilly and Company Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Eli Lilly and Company Recent Developments and Future Plans
2.11 Gilead Sciences, Inc
2.11.1 Gilead Sciences, Inc Details
2.11.2 Gilead Sciences, Inc Major Business
2.11.3 Gilead Sciences, Inc Targeted Protein Degradation Product and Solutions
2.11.4 Gilead Sciences, Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Gilead Sciences, Inc Recent Developments and Future Plans
2.12 GlaxoSmithKline plc
2.12.1 GlaxoSmithKline plc Details
2.12.2 GlaxoSmithKline plc Major Business
2.12.3 GlaxoSmithKline plc Targeted Protein Degradation Product and Solutions
2.12.4 GlaxoSmithKline plc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.13 Merck KGaA
2.13.1 Merck KGaA Details
2.13.2 Merck KGaA Major Business
2.13.3 Merck KGaA Targeted Protein Degradation Product and Solutions
2.13.4 Merck KGaA Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Merck KGaA Recent Developments and Future Plans
2.14 Mission Therapeutics
2.14.1 Mission Therapeutics Details
2.14.2 Mission Therapeutics Major Business
2.14.3 Mission Therapeutics Targeted Protein Degradation Product and Solutions
2.14.4 Mission Therapeutics Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Mission Therapeutics Recent Developments and Future Plans
2.15 Novartis AG
2.15.1 Novartis AG Details
2.15.2 Novartis AG Major Business
2.15.3 Novartis AG Targeted Protein Degradation Product and Solutions
2.15.4 Novartis AG Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Novartis AG Recent Developments and Future Plans
2.16 Pfizer Inc
2.16.1 Pfizer Inc Details
2.16.2 Pfizer Inc Major Business
2.16.3 Pfizer Inc Targeted Protein Degradation Product and Solutions
2.16.4 Pfizer Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 Pfizer Inc Recent Developments and Future Plans
2.17 Promega
2.17.1 Promega Details
2.17.2 Promega Major Business
2.17.3 Promega Targeted Protein Degradation Product and Solutions
2.17.4 Promega Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Promega Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Targeted Protein Degradation Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Targeted Protein Degradation Players Market Share
3.2.2 Top 10 Targeted Protein Degradation Players Market Share
3.2.3 Market Competition Trend
3.3 Targeted Protein Degradation Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Targeted Protein Degradation Revenue and Market Share by Type (2016-2021)
4.2 Global Targeted Protein Degradation Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Targeted Protein Degradation Revenue Market Share by Application (2016-2021)
5.2 Targeted Protein Degradation Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Targeted Protein Degradation Revenue by Type (2017-2032)
6.2 North America Targeted Protein Degradation Revenue by Application (2017-2032)
6.3 North America Targeted Protein Degradation Market Size by Country
6.3.1 North America Targeted Protein Degradation Revenue by Country (2017-2032)
6.3.2 United States Targeted Protein Degradation Market Size and Forecast (2017-2032)
6.3.3 Canada Targeted Protein Degradation Market Size and Forecast (2017-2032)
6.3.4 Mexico Targeted Protein Degradation Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Targeted Protein Degradation Revenue by Type (2017-2032)
7.2 Europe Targeted Protein Degradation Revenue by Application (2017-2032)
7.3 Europe Targeted Protein Degradation Market Size by Country
7.3.1 Europe Targeted Protein Degradation Revenue by Country (2017-2032)
7.3.2 Germany Targeted Protein Degradation Market Size and Forecast (2017-2032)
7.3.3 France Targeted Protein Degradation Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Targeted Protein Degradation Market Size and Forecast (2017-2032)
7.3.5 Russia Targeted Protein Degradation Market Size and Forecast (2017-2032)
7.3.6 Italy Targeted Protein Degradation Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Targeted Protein Degradation Revenue by Type (2017-2032)
8.2 Asia-Pacific Targeted Protein Degradation Revenue by Application (2017-2032)
8.3 Asia-Pacific Targeted Protein Degradation Market Size by Region
8.3.1 Asia-Pacific Targeted Protein Degradation Revenue by Region (2017-2032)
8.3.2 China Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.3 Japan Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.4 South Korea Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.5 India Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.7 Australia Targeted Protein Degradation Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Targeted Protein Degradation Revenue by Type (2017-2032)
9.2 South America Targeted Protein Degradation Revenue by Application (2017-2032)
9.3 South America Targeted Protein Degradation Market Size by Country
9.3.1 South America Targeted Protein Degradation Revenue by Country (2017-2032)
9.3.2 Brazil Targeted Protein Degradation Market Size and Forecast (2017-2032)
9.3.3 Argentina Targeted Protein Degradation Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Targeted Protein Degradation Revenue by Type (2017-2032)
10.2 Middle East & Africa Targeted Protein Degradation Revenue by Application (2017-2032)
10.3 Middle East & Africa Targeted Protein Degradation Market Size by Country
10.3.1 Middle East & Africa Targeted Protein Degradation Revenue by Country (2017-2032)
10.3.2 Turkey Targeted Protein Degradation Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Targeted Protein Degradation Market Size and Forecast (2017-2032)
10.3.4 UAE Targeted Protein Degradation Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Targeted Protein Degradation
1.2 Classification of Targeted Protein Degradation by Type
1.2.1 Overview: Global Targeted Protein Degradation Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Targeted Protein Degradation Revenue Market Share by Type in 2022
1.2.3 Oral
1.2.4 Intravenous
1.2.5 Others
1.3 Global Targeted Protein Degradation Market by Application
1.3.1 Overview: Global Targeted Protein Degradation Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Hospital
1.3.3 Research Institute
1.4 Global Targeted Protein Degradation Market Size & Forecast
1.5 Global Targeted Protein Degradation Market Size and Forecast by Region
1.5.1 Global Targeted Protein Degradation Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Targeted Protein Degradation Market Size by Region, (2016-2021)
1.5.3 North America Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.5.4 Europe Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.5.6 South America Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Targeted Protein Degradation Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Targeted Protein Degradation Market Drivers
1.6.2 Targeted Protein Degradation Market Restraints
1.6.3 Targeted Protein Degradation Trends Analysis
2 Company Profiles
2.1 5AM Venture Management LLC
2.1.1 5AM Venture Management LLC Details
2.1.2 5AM Venture Management LLC Major Business
2.1.3 5AM Venture Management LLC Targeted Protein Degradation Product and Solutions
2.1.4 5AM Venture Management LLC Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 5AM Venture Management LLC Recent Developments and Future Plans
2.2 AbbVie Inc
2.2.1 AbbVie Inc Details
2.2.2 AbbVie Inc Major Business
2.2.3 AbbVie Inc Targeted Protein Degradation Product and Solutions
2.2.4 AbbVie Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 AbbVie Inc Recent Developments and Future Plans
2.3 Almac Group
2.3.1 Almac Group Details
2.3.2 Almac Group Major Business
2.3.3 Almac Group Targeted Protein Degradation Product and Solutions
2.3.4 Almac Group Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Almac Group Recent Developments and Future Plans
2.4 Amgen Inc.
2.4.1 Amgen Inc. Details
2.4.2 Amgen Inc. Major Business
2.4.3 Amgen Inc. Targeted Protein Degradation Product and Solutions
2.4.4 Amgen Inc. Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Amgen Inc. Recent Developments and Future Plans
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Targeted Protein Degradation Product and Solutions
2.5.4 Bayer AG Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Bayer AG Recent Developments and Future Plans
2.6 Biogen Inc.
2.6.1 Biogen Inc. Details
2.6.2 Biogen Inc. Major Business
2.6.3 Biogen Inc. Targeted Protein Degradation Product and Solutions
2.6.4 Biogen Inc. Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Biogen Inc. Recent Developments and Future Plans
2.7 C4 Therapeutics
2.7.1 C4 Therapeutics Details
2.7.2 C4 Therapeutics Major Business
2.7.3 C4 Therapeutics Targeted Protein Degradation Product and Solutions
2.7.4 C4 Therapeutics Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 C4 Therapeutics Recent Developments and Future Plans
2.8 Cosmo Bio USA
2.8.1 Cosmo Bio USA Details
2.8.2 Cosmo Bio USA Major Business
2.8.3 Cosmo Bio USA Targeted Protein Degradation Product and Solutions
2.8.4 Cosmo Bio USA Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Cosmo Bio USA Recent Developments and Future Plans
2.9 Covance Inc
2.9.1 Covance Inc Details
2.9.2 Covance Inc Major Business
2.9.3 Covance Inc Targeted Protein Degradation Product and Solutions
2.9.4 Covance Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Covance Inc Recent Developments and Future Plans
2.10 Eli Lilly and Company
2.10.1 Eli Lilly and Company Details
2.10.2 Eli Lilly and Company Major Business
2.10.3 Eli Lilly and Company Targeted Protein Degradation Product and Solutions
2.10.4 Eli Lilly and Company Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Eli Lilly and Company Recent Developments and Future Plans
2.11 Gilead Sciences, Inc
2.11.1 Gilead Sciences, Inc Details
2.11.2 Gilead Sciences, Inc Major Business
2.11.3 Gilead Sciences, Inc Targeted Protein Degradation Product and Solutions
2.11.4 Gilead Sciences, Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Gilead Sciences, Inc Recent Developments and Future Plans
2.12 GlaxoSmithKline plc
2.12.1 GlaxoSmithKline plc Details
2.12.2 GlaxoSmithKline plc Major Business
2.12.3 GlaxoSmithKline plc Targeted Protein Degradation Product and Solutions
2.12.4 GlaxoSmithKline plc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.13 Merck KGaA
2.13.1 Merck KGaA Details
2.13.2 Merck KGaA Major Business
2.13.3 Merck KGaA Targeted Protein Degradation Product and Solutions
2.13.4 Merck KGaA Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Merck KGaA Recent Developments and Future Plans
2.14 Mission Therapeutics
2.14.1 Mission Therapeutics Details
2.14.2 Mission Therapeutics Major Business
2.14.3 Mission Therapeutics Targeted Protein Degradation Product and Solutions
2.14.4 Mission Therapeutics Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Mission Therapeutics Recent Developments and Future Plans
2.15 Novartis AG
2.15.1 Novartis AG Details
2.15.2 Novartis AG Major Business
2.15.3 Novartis AG Targeted Protein Degradation Product and Solutions
2.15.4 Novartis AG Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Novartis AG Recent Developments and Future Plans
2.16 Pfizer Inc
2.16.1 Pfizer Inc Details
2.16.2 Pfizer Inc Major Business
2.16.3 Pfizer Inc Targeted Protein Degradation Product and Solutions
2.16.4 Pfizer Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 Pfizer Inc Recent Developments and Future Plans
2.17 Promega
2.17.1 Promega Details
2.17.2 Promega Major Business
2.17.3 Promega Targeted Protein Degradation Product and Solutions
2.17.4 Promega Targeted Protein Degradation Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Promega Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Targeted Protein Degradation Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Targeted Protein Degradation Players Market Share
3.2.2 Top 10 Targeted Protein Degradation Players Market Share
3.2.3 Market Competition Trend
3.3 Targeted Protein Degradation Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Targeted Protein Degradation Revenue and Market Share by Type (2016-2021)
4.2 Global Targeted Protein Degradation Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Targeted Protein Degradation Revenue Market Share by Application (2016-2021)
5.2 Targeted Protein Degradation Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Targeted Protein Degradation Revenue by Type (2017-2032)
6.2 North America Targeted Protein Degradation Revenue by Application (2017-2032)
6.3 North America Targeted Protein Degradation Market Size by Country
6.3.1 North America Targeted Protein Degradation Revenue by Country (2017-2032)
6.3.2 United States Targeted Protein Degradation Market Size and Forecast (2017-2032)
6.3.3 Canada Targeted Protein Degradation Market Size and Forecast (2017-2032)
6.3.4 Mexico Targeted Protein Degradation Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Targeted Protein Degradation Revenue by Type (2017-2032)
7.2 Europe Targeted Protein Degradation Revenue by Application (2017-2032)
7.3 Europe Targeted Protein Degradation Market Size by Country
7.3.1 Europe Targeted Protein Degradation Revenue by Country (2017-2032)
7.3.2 Germany Targeted Protein Degradation Market Size and Forecast (2017-2032)
7.3.3 France Targeted Protein Degradation Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Targeted Protein Degradation Market Size and Forecast (2017-2032)
7.3.5 Russia Targeted Protein Degradation Market Size and Forecast (2017-2032)
7.3.6 Italy Targeted Protein Degradation Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Targeted Protein Degradation Revenue by Type (2017-2032)
8.2 Asia-Pacific Targeted Protein Degradation Revenue by Application (2017-2032)
8.3 Asia-Pacific Targeted Protein Degradation Market Size by Region
8.3.1 Asia-Pacific Targeted Protein Degradation Revenue by Region (2017-2032)
8.3.2 China Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.3 Japan Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.4 South Korea Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.5 India Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Targeted Protein Degradation Market Size and Forecast (2017-2032)
8.3.7 Australia Targeted Protein Degradation Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Targeted Protein Degradation Revenue by Type (2017-2032)
9.2 South America Targeted Protein Degradation Revenue by Application (2017-2032)
9.3 South America Targeted Protein Degradation Market Size by Country
9.3.1 South America Targeted Protein Degradation Revenue by Country (2017-2032)
9.3.2 Brazil Targeted Protein Degradation Market Size and Forecast (2017-2032)
9.3.3 Argentina Targeted Protein Degradation Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Targeted Protein Degradation Revenue by Type (2017-2032)
10.2 Middle East & Africa Targeted Protein Degradation Revenue by Application (2017-2032)
10.3 Middle East & Africa Targeted Protein Degradation Market Size by Country
10.3.1 Middle East & Africa Targeted Protein Degradation Revenue by Country (2017-2032)
10.3.2 Turkey Targeted Protein Degradation Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Targeted Protein Degradation Market Size and Forecast (2017-2032)
10.3.4 UAE Targeted Protein Degradation Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI